Request Demo
Last update 22 Nov 2025
ABT-652
Last update 22 Nov 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms ABT 652 |
Target |
Action modulators |
Mechanism H3 receptor modulators(Histamine H3 receptor modulators) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
4
Clinical Trials associated with ABT-652NCT01579279
A Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Diabetic Neuropathic Pain
NCT01444365
A Phase 2, Randomized Withdrawal Study of the Analgesic Efficacy and Safety of ABT-652 as an Add On Therapy in Subjects With Osteoarthritis of the Knee Experiencing Partial Benefit of a Nonsteroidal Anti-Inflammatory Drug
NCT01207115
A Global Multicenter, Randomized, Double-Blind, Placebo- and Active-Controlled Study Comparing the Analgesic Efficacy and Safety of ABT-652 to Placebo in Subjects With Osteoarthritis Pain of the Knee
100 Clinical Results associated with ABT-652
Login to view more data
100 Translational Medicine associated with ABT-652
Login to view more data
100 Patents (Medical) associated with ABT-652
Login to view more data
100 Deals associated with ABT-652
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetic peripheral neuropathic pain | Phase 2 | United States | 01 Apr 2012 | |
| Osteoarthritis, Knee | Phase 2 | United States | 01 Sep 2010 | |
| Osteoarthritis, Knee | Phase 2 | Australia | 01 Sep 2010 | |
| Osteoarthritis, Knee | Phase 2 | Canada | 01 Sep 2010 | |
| Osteoarthritis, Knee | Phase 2 | Chile | 01 Sep 2010 | |
| Osteoarthritis, Knee | Phase 2 | Puerto Rico | 01 Sep 2010 | |
| Excessive Daytime Sleepiness | Phase 1 | United States | 01 Aug 2010 | |
| Idiopathic Hypersomnia | Phase 1 | United States | 01 Aug 2010 | |
| Narcolepsy | Phase 1 | United States | 01 Aug 2010 | |
| Sleep Apnea, Obstructive | Phase 1 | United States | 01 Aug 2010 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free